Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer

Mikayo Aragaki, Kiichiro Tsuchiya, Ryuichi Okamoto, Sanae Yoshioka, Tetsuya Nakamura, Naoya Sakamoto, Takanori Kanai, Mamoru Watanabe

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Atoh1 plays a crucial role in intestinal cell differentiation. We have demonstrated that its human homolog Hath1 protein is targeted by the Wnt-GSK3 axis, resulting in the proteasomal degradation in human colon cancer. However, the contribution of Hath1 degradation to the undifferentiated state of colon cancer remains unknown. In this study, we demonstrated that both constitutive expression of mutant Hath1 and stabilization of Hath1 protein by a GSK3 inhibitor in colon cancer cells increased the expression of MUC2 known as a representative function of differentiated goblet cells. This means that Hath1 protein degradation may be required for maintaining the undifferentiated state of colon cancers, and that GSK3 inhibitors have potential for use in cancer therapy.

Original languageEnglish
Pages (from-to)923-929
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume368
Issue number4
DOIs
Publication statusPublished - 2008 Apr 18
Externally publishedYes

Fingerprint

Colonic Neoplasms
Degradation
Proteins
Goblet Cells
Stabilization
Cells
Proteolysis
Cell Differentiation
Neoplasms
Therapeutics

Keywords

  • Atoh1
  • Colon cancer
  • Differentiation
  • GSK3β
  • Hath1
  • Proteasomal degradation
  • Wnt

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer. / Aragaki, Mikayo; Tsuchiya, Kiichiro; Okamoto, Ryuichi; Yoshioka, Sanae; Nakamura, Tetsuya; Sakamoto, Naoya; Kanai, Takanori; Watanabe, Mamoru.

In: Biochemical and Biophysical Research Communications, Vol. 368, No. 4, 18.04.2008, p. 923-929.

Research output: Contribution to journalArticle

Aragaki, Mikayo ; Tsuchiya, Kiichiro ; Okamoto, Ryuichi ; Yoshioka, Sanae ; Nakamura, Tetsuya ; Sakamoto, Naoya ; Kanai, Takanori ; Watanabe, Mamoru. / Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer. In: Biochemical and Biophysical Research Communications. 2008 ; Vol. 368, No. 4. pp. 923-929.
@article{599fd5760964468a9fc4cc37704c1c4b,
title = "Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer",
abstract = "Atoh1 plays a crucial role in intestinal cell differentiation. We have demonstrated that its human homolog Hath1 protein is targeted by the Wnt-GSK3 axis, resulting in the proteasomal degradation in human colon cancer. However, the contribution of Hath1 degradation to the undifferentiated state of colon cancer remains unknown. In this study, we demonstrated that both constitutive expression of mutant Hath1 and stabilization of Hath1 protein by a GSK3 inhibitor in colon cancer cells increased the expression of MUC2 known as a representative function of differentiated goblet cells. This means that Hath1 protein degradation may be required for maintaining the undifferentiated state of colon cancers, and that GSK3 inhibitors have potential for use in cancer therapy.",
keywords = "Atoh1, Colon cancer, Differentiation, GSK3β, Hath1, Proteasomal degradation, Wnt",
author = "Mikayo Aragaki and Kiichiro Tsuchiya and Ryuichi Okamoto and Sanae Yoshioka and Tetsuya Nakamura and Naoya Sakamoto and Takanori Kanai and Mamoru Watanabe",
year = "2008",
month = "4",
day = "18",
doi = "10.1016/j.bbrc.2008.02.011",
language = "English",
volume = "368",
pages = "923--929",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer

AU - Aragaki, Mikayo

AU - Tsuchiya, Kiichiro

AU - Okamoto, Ryuichi

AU - Yoshioka, Sanae

AU - Nakamura, Tetsuya

AU - Sakamoto, Naoya

AU - Kanai, Takanori

AU - Watanabe, Mamoru

PY - 2008/4/18

Y1 - 2008/4/18

N2 - Atoh1 plays a crucial role in intestinal cell differentiation. We have demonstrated that its human homolog Hath1 protein is targeted by the Wnt-GSK3 axis, resulting in the proteasomal degradation in human colon cancer. However, the contribution of Hath1 degradation to the undifferentiated state of colon cancer remains unknown. In this study, we demonstrated that both constitutive expression of mutant Hath1 and stabilization of Hath1 protein by a GSK3 inhibitor in colon cancer cells increased the expression of MUC2 known as a representative function of differentiated goblet cells. This means that Hath1 protein degradation may be required for maintaining the undifferentiated state of colon cancers, and that GSK3 inhibitors have potential for use in cancer therapy.

AB - Atoh1 plays a crucial role in intestinal cell differentiation. We have demonstrated that its human homolog Hath1 protein is targeted by the Wnt-GSK3 axis, resulting in the proteasomal degradation in human colon cancer. However, the contribution of Hath1 degradation to the undifferentiated state of colon cancer remains unknown. In this study, we demonstrated that both constitutive expression of mutant Hath1 and stabilization of Hath1 protein by a GSK3 inhibitor in colon cancer cells increased the expression of MUC2 known as a representative function of differentiated goblet cells. This means that Hath1 protein degradation may be required for maintaining the undifferentiated state of colon cancers, and that GSK3 inhibitors have potential for use in cancer therapy.

KW - Atoh1

KW - Colon cancer

KW - Differentiation

KW - GSK3β

KW - Hath1

KW - Proteasomal degradation

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=40049092947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40049092947&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.02.011

DO - 10.1016/j.bbrc.2008.02.011

M3 - Article

VL - 368

SP - 923

EP - 929

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -